Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-26-002613
Filing Date
2026-03-25
Accepted
2026-03-25 15:20:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3674
  Complete submission text file 0001959173-26-002613.txt   5144
Mailing Address C/O ESPERION THERAPEUTICS, INC. 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address
Bartram Richard (Reporting) CIK: 0001723729 (see all company filings)

Type: 144

Mailing Address 11711 N. MERIDIAN STREET SUITE 300 CARMEL IN 46032
Business Address 11711 N. MERIDIAN STREET SUITE 300 CARMEL IN 46032 3179893100
MBX Biosciences, Inc. (Subject) CIK: 0001776111 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-42272 | Film No.: 26791777
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)